1. Robert W. Yeh et al. JACC 2017;70:2213-2223
Cumulative Incidence of MI or Stent Thrombosis, MACCE, and GUSTO Moderate/Severe Bleeding From 12 to 30 Months After Randomization Cumulative incidence of (A) myocardial infarction (MI) or stent thrombosis, (B) major adverse cardiovascular or cerebrovascular event(s) (MACCE), and (C) GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries) moderate/severe (Mod/Sev) bleeding from 12 to 30 months after randomization, according to randomization group in subjects with and without anatomically complex lesions. Consistency in treatment effect of continued thienopyridine was observed in subjects with and without anatomically complex lesions in the 12- to 30-month time period for all major endpoints.
Robert W. Yeh et al. JACC 2017;70:
2017 American College of Cardiology Foundation